Characteristics of the EX and ER groups are presented
in Table 1. At baseline, the prevalence of NASH was not
different between ER and EX groups (67% vs 80%, P
= 0.64). Primary results of the randomised controlled
trial are reported elsewhere[20]. Briefly, in the ER group
steatosis and the NAS decreased significantly, while in
the EX group neither steatosis nor NAS decreased signi-
ficantly. Skeletal muscle insulin resistance (M-value)
improved significantly in response to EX, while it did not
improve in patients from the ER group.